Regulation of hepatic 7 alpha-hydroxylase expression by dietary psyllium in the hamster.
Soluble fiber consistently lowers plasma total and low density lipoprotein (LDL)-cholesterol concentrations in humans and various animal models including the hamster; however, the mechanism of this effect remains incompletely defined. We performed studies to determine the activity of dietary psyllium on hepatic 7 alpha-hydroxylase, 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase and LDL receptor expression in the hamster. In animals fed a cholesterol-free semisynthetic diet containing 7.5% cellulose (avicel) as a fiber source, substitution of psyllium for avicel increased hepatic 7 alpha-hydroxylase activity and mRNA levels by 3-4-fold. Comparable effects on 7 alpha-hydroxylase expression were observed with 1% cholestyramine. Psyllium also increased hepatic 7 alpha-hydroxylase activity and mRNA in animals fed a diet enriched with cholesterol and triglyceride. Activation of 7 alpha-hydroxylase was associated with an increase in hepatic cholesterol synthesis that was apparently not fully compensatory since the cholesterol content of the liver declined. Although dietary psyllium did not increase hepatic LDL receptor expression in animals fed the cholesterol-free, very-low-fat diet, it did increase (or at least restore) receptor expression that had been downregulated by dietary cholesterol and triglyceride. Thus, 7.5% dietary psyllium produced effects on hepatic 7 alpha-hydroxylase and LDL metabolism that were similar to those of 1% cholestyramine. Induction of hepatic 7 alpha-hydroxylase activity by dietary psyllium may account, in large part, for the hypocholesterolemic effect of this soluble fiber.
Horton
J D
JD
Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas 75235.
Cuthbert
J A
JA
Spady
D K
DK
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001189:Aryl Hydrocarbon Hydroxylases; D001483:Base Sequence; D002482:Cellulose / Q000494:pharmacology; D002784:Cholesterol / Q000096:biosynthesis / Q000097:blood; D008078:Cholesterol, LDL / Q000378:metabolism; D002792:Cholestyramine Resin / Q000494:pharmacology; D006224:Cricetinae; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis* / Q000235:genetics; D004043:Dietary Fiber; D004305:Dose-Response Relationship, Drug; D015971:Gene Expression Regulation, Enzymologic; D008099:Liver / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008969:Molecular Sequence Data; D011620:Psyllium / Q000494:pharmacology*; D012333:RNA, Messenger / Q000032:analysis; D011973:Receptors, LDL / Q000235:genetics / Q000378:metabolism; D013250:Steroid Hydroxylases / Q000096:biosynthesis* / Q000235:genetics; D015854:Up-Regulation
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D004043:Dietary Fiber; D012333:RNA, Messenger; D011973:Receptors, LDL; D002792:Cholestyramine Resin; D011620:Psyllium; D002482:Cellulose; D003577:Cytochrome P-450 Enzyme System; D002784:Cholesterol; D013250:Steroid Hydroxylases; D001189:Aryl Hydrocarbon Hydroxylases; C029009:steroid hormone 7-alpha-hydroxylase